Case Report

Published on 31 May 2023

Case Report: Should Regorafenib be prescribed as a continuous schedule in gastrointestinal stromal tumors? Three case reports on Regorafenib personalized schedule

in Pharmacology of Anti-Cancer Drugs

Maria Susanna Grimaudo
Alice Laffi
Nicolò Gennaro
Roberta Fazio
Federico D’Orazio
Laura Samà
Licia Vanessa Siracusano
Federico Sicoli
Salvatore Lorenzo Renne
Armando Santoro

Frontiers in Oncology

doi 10.3389/fonc.2023.1190123

1,565 views
1 citation

Original Research

Published on 29 May 2023

Efficacy and safety of fondaparinux in preventing venous thromboembolism in Chinese cancer patients: a single-arm, multicenter, retrospective study

in Pharmacology of Anti-Cancer Drugs

Lei Wang
Zhong Su
Chunying Xie
Ruijun Li
Wei Pan
Lu Xu
Fei Chen
Gang Cheng

Frontiers in Oncology

doi 10.3389/fonc.2023.1165437

1,675 views
3 citations

Original Research

Published on 26 May 2023

All-oral low-dose chemotherapy TEPIP is effective and well-tolerated in patients with peripheral T-cell lymphoma

in Pharmacology of Anti-Cancer Drugs

Matthias A. Fante
Dennis C. Harrer
Barbara Zartner
Florian Lüke
Stephanie Mayer
Karin Menhart
Albrecht Reichle
Wolfgang Herr
Martin Vogelhuber
Daniel Heudobler

Frontiers in Oncology

doi 10.3389/fonc.2023.1177330

2,120 views
2 citations

Original Research

Published on 25 May 2023

Indolyl-chalcone derivatives trigger apoptosis in cisplatin-resistant mesothelioma cells through aberrant tubulin polymerization and deregulation of microtubule-associated proteins

in Pharmacology of Anti-Cancer Drugs

Sophia Steinlein
Frank Essmann
Amanda Franceschini Ghilardi
Heike Horn
Julia Schüler
Angelika Hausser
Lijun Sun
German Ott
Claudia Kalla

Frontiers in Oncology

doi 10.3389/fonc.2023.1190988

2,112 views
1 citation

Opinion

Published on 18 May 2023

Development of ZD2767P–carboxypeptidase G2–ultrasound therapy against cisplatin-resistant cancer

in Pharmacology of Anti-Cancer Drugs

Tinghe Yu
Xinya Li

Frontiers in Oncology

doi 10.3389/fonc.2023.1151613

2,101 views
4 citations

Original Research

Published on 15 May 2023

Dihydromyricetin functions as a tumor suppressor in hepatoblastoma by regulating SOD1/ROS pathway

in Pharmacology of Anti-Cancer Drugs

Tong Guo
Xitong Wang
Gensheng Zhang
Tian Xia
Runzhi Zhu
Jinfa Tou

Frontiers in Oncology

doi 10.3389/fonc.2023.1160548

1,679 views
4 citations

Original Research

Published on 12 May 2023

The genomic landscape of sensitivity to arsenic trioxide uncovered by genome-wide CRISPR-Cas9 screening

in Pharmacology of Anti-Cancer Drugs

Jun-Zhu Chen
Li-Na Wang
Xue-Qun Luo
Yan-Lai Tang

Frontiers in Oncology

doi 10.3389/fonc.2023.1178686

2,829 views
1 citation

Systematic Review

Published on 12 May 2023

Hyperthermia intravesical chemotherapy acts as a promising alternative to bacillus Calmette–Guérin instillation in non-muscle-invasive bladder cancer: a network meta-analysis

in Pharmacology of Anti-Cancer Drugs

Na Zeng
Meng-Yao Xu
Jian-Xuan Sun
Chen-Qian Liu
Jin-Zhou Xu
Ye An
Xing-Yu Zhong
Si-Yang Ma
Hao-Dong He
Qi-Dong Xia

Frontiers in Oncology

doi 10.3389/fonc.2023.1164932

2,603 views
7 citations

Perspective

Published on 05 May 2023

Should personalised dosing have a role in cancer treatment?

in Pharmacology of Anti-Cancer Drugs

Claire C. Villette
David Orrell
Jim Millen
Christophe Chassagnole

Frontiers in Oncology

doi 10.3389/fonc.2023.1154493

1,793 views

Review

Published on 03 May 2023

Novel targeted drugs for follicular and marginal zone lymphoma: a comprehensive review

in Pharmacology of Anti-Cancer Drugs

Andrea Rivero
Pablo Mozas
Laura Magnano
Armando López-Guillermo

Frontiers in Oncology

doi 10.3389/fonc.2023.1170394

6,666 views
3 citations

Original Research

Published on 01 May 2023

Characteristic of molecular subtype based on lysosome-associated genes reveals clinical prognosis and immune infiltration of gastric cancer

in Pharmacology of Anti-Cancer Drugs

Maodong Hu
Ruifeng Chong
Weilin Liu
Shuangyong Liu
Xiaolei Liu

Frontiers in Oncology

doi 10.3389/fonc.2023.1155418

2,403 views
5 citations

Original Research

Published on 18 Apr 2023

Combined treatment of disulfiram with PARP inhibitors suppresses ovarian cancer

in Pharmacology of Anti-Cancer Drugs

Bin Tang
Min Wu
Lin Zhang
Shuyi Jian
Shiyi Lv
Tongyuan Lin
Shuangshuang Zhu
Layang Liu
Yixue Wang
Zhengfang Yi

Frontiers in Oncology

doi 10.3389/fonc.2023.1154073

1,975 views
5 citations

Original Research

Published on 17 Apr 2023

5-Demethylnobiletin mediates cell cycle arrest and apoptosis via the ERK1/2/AKT/STAT3 signaling pathways in glioblastoma cells

in Pharmacology of Anti-Cancer Drugs

Xuehua Zhang
Leilei Zhao
Jinlong Xiao
Yudi Wang
Yunmeng Li
Chaoqun Zhu
He Zhang
Yurui Zhang
Xiao Zhu
Yucui Dong

Frontiers in Oncology

doi 10.3389/fonc.2023.1143664

1,971 views
2 citations

Correction

Published on 14 Apr 2023

Corrigendum: Variations in circulating levels of angiopoietin-2 over time are predictive of ramucirumab–paclitaxel therapy outcome in advanced gastric cancer: results of prospective study

in Pharmacology of Anti-Cancer Drugs

Rosalba D’Alessandro
Maria Grazia Refolo
Annalisa Schirizzi
Giampiero De Leonardis
Rossella Donghia
Vito Guerra
Gianluigi Giannelli
Ivan Roberto Lolli
Maria Maddalena Laterza
Ferdinando De Vita

Frontiers in Oncology

doi 10.3389/fonc.2023.1187014

712 views
1 citation

Perspective

Published on 14 Apr 2023

Novel pharmacological and dietary approaches to target mTOR in B-cell acute lymphoblastic leukemia

in Pharmacology of Anti-Cancer Drugs

Roberta Buono
Muneera Alhaddad
David A. Fruman

Frontiers in Oncology

doi 10.3389/fonc.2023.1162694

2,278 views
3 citations

Original Research

Published on 14 Apr 2023

Development and evaluation of novel artemisinin-isatin hybrids with potential anti-leukemic cytotoxicity

in Pharmacology of Anti-Cancer Drugs

Peng Wang
Zhe Zhang
Wei Cao
Xuan Zhang

Frontiers in Oncology

doi 10.3389/fonc.2023.1112369

1,300 views

Navigation group

Articles

Case Report: Should Regorafenib be prescribed as a continuous schedule in gastrointestinal stromal tumors? Three case reports on Regorafenib personalized schedule

Efficacy and safety of fondaparinux in preventing venous thromboembolism in Chinese cancer patients: a single-arm, multicenter, retrospective study

All-oral low-dose chemotherapy TEPIP is effective and well-tolerated in patients with peripheral T-cell lymphoma

Indolyl-chalcone derivatives trigger apoptosis in cisplatin-resistant mesothelioma cells through aberrant tubulin polymerization and deregulation of microtubule-associated proteins

Development of ZD2767P–carboxypeptidase G2–ultrasound therapy against cisplatin-resistant cancer

Dihydromyricetin functions as a tumor suppressor in hepatoblastoma by regulating SOD1/ROS pathway

The genomic landscape of sensitivity to arsenic trioxide uncovered by genome-wide CRISPR-Cas9 screening

Hyperthermia intravesical chemotherapy acts as a promising alternative to bacillus Calmette–Guérin instillation in non-muscle-invasive bladder cancer: a network meta-analysis

Should personalised dosing have a role in cancer treatment?

Novel targeted drugs for follicular and marginal zone lymphoma: a comprehensive review

Characteristic of molecular subtype based on lysosome-associated genes reveals clinical prognosis and immune infiltration of gastric cancer

Combined treatment of disulfiram with PARP inhibitors suppresses ovarian cancer

5-Demethylnobiletin mediates cell cycle arrest and apoptosis via the ERK1/2/AKT/STAT3 signaling pathways in glioblastoma cells

Corrigendum: Variations in circulating levels of angiopoietin-2 over time are predictive of ramucirumab–paclitaxel therapy outcome in advanced gastric cancer: results of prospective study

Novel pharmacological and dietary approaches to target mTOR in B-cell acute lymphoblastic leukemia

Development and evaluation of novel artemisinin-isatin hybrids with potential anti-leukemic cytotoxicity